Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SNY

Sanofi ADR

Dec 24 • 04:00PM ET

48.36

+0.04 0.08 %

Healthcare • Drug Manufacturers - General • France • NASD

Peers: NVS PFE MRK GSK BMY LLY AZN JNJ ABBV AMGN

| Held by: PVAL PPH FVD PID AVDE FENI BASV BDYN APIE BUSA

Scroll to Statements

Index	-	P/E	12.07	EPS (ttm)	4.01	Insider Own	0.00%	Shs Outstand	2.61B	Perf Week	0.46%
Market Cap	116.92B	Forward P/E	9.83	EPS next Y	4.92	Insider Trans	-	Shs Float	2.42B	Perf Month	-1.61%
Enterprise Value	125.37B	PEG	0.79	EPS next Q	0.83	Inst Own	9.87%	Short Float	0.26%	Perf Quarter	7.30%
Income	9.94B	P/S	2.70	EPS this Y	22.27%	Inst Trans	-0.88%	Short Ratio	2.10	Perf Half Y	-0.02%
Sales	43.23B	P/B	1.43	EPS next Y	8.39%	ROA	4.70%	Short Interest	6.25M	Perf YTD	0.27%
Book/sh	33.76	P/C	6.48	EPS next 5Y	12.44%	ROE	8.39%	52W High	60.12 -19.55%	Perf Year	1.36%
Cash/sh	7.46	P/FCF	10.84	EPS past 3/5Y	-6.46% 13.05%	ROIC	9.99%	52W Low	44.62 8.39%	Perf 3Y	2.94%
Dividend Est.	2.38 (4.93%)	EV/EBITDA	8.32	Sales past 3/5Y	-0.15% 1.91%	Gross Margin	65.42%	Volatility	1.15% 1.38%	Perf 5Y	2.40%
Dividend TTM	2.21 (4.57%)	EV/Sales	2.90	EPS Y/Y TTM	120.62%	Oper. Margin	24.88%	ATR (14)	0.78	Perf 10Y	11.43%
Dividend Ex-Date	May 09, 2025	Quick Ratio	0.94	Sales Y/Y TTM	-9.32%	Profit Margin	22.98%	RSI (14)	45.67	Recom	1.75
Dividend Gr. 3/5Y	8.29% 6.46%	Current Ratio	1.27	EPS Q/Q	-	SMA20	-0.72%	Beta	0.44	Target Price	61.00
Payout	66.53%	Debt/Eq	0.32	Sales Q/Q	-	SMA50	-2.70%	Rel Volume	0.27	Prev Close	48.32
Employees	84587	LT Debt/Eq	0.21	Earnings	Oct 24 BMO	SMA200	-3.58%	Avg Volume	2.97M	Price	48.36
IPO	Jul 01, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.11% 3.35%	Trades		Volume	807,279	Change	0.08%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Downgrade	Guggenheim	Buy → Neutral
Dec-08-25	Downgrade	JP Morgan	Overweight → Neutral
Sep-08-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$58
Sep-02-25	Upgrade	Deutsche Bank	Hold → Buy
Aug-08-25	Upgrade	JP Morgan	Neutral → Overweight
Apr-15-25	Initiated	Exane BNP Paribas	Outperform	$65
Mar-21-25	Initiated	Goldman	Neutral	$65
Jan-30-25	Upgrade	Deutsche Bank	Sell → Hold
Jul-26-24	Reiterated	Argus	Buy	$55 → $60
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$55
Jan-16-24	Resumed	UBS	Buy
Dec-05-23	Downgrade	JP Morgan	Overweight → Neutral
Oct-30-23	Downgrade	Stifel	Buy → Hold
Sep-06-23	Upgrade	Berenberg	Hold → Buy
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-28-23	Downgrade	Deutsche Bank	Hold → Sell
Mar-27-23	Upgrade	Barclays	Equal Weight → Overweight
Dec-13-22	Resumed	Morgan Stanley	Overweight
Aug-12-22	Upgrade	Deutsche Bank	Sell → Hold
Aug-09-22	Downgrade	UBS	Buy → Neutral

Show Previous Ratings

Today 03:55PM	Why Dynavax Stock Soared Today (Motley Fool)
01:24PM	How major US stock indexes fared Wednesday, 12/24/2025 (Associated Press)
01:04PM	Sanofi To Buy Vaccine Maker Dynavax For $2.2 Billion (Investor's Business Daily)
12:08PM	This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. (Barrons.com)
11:55AM	Dynavax Technologies Stock Soars on Buyout Buzz (Schaeffer's Research)
11:24AM	Loading…
11:24AM	Sanofi to Acquire Dynavax for $2.2 Billion, Expanding Vaccine Portfolio (GuruFocus.com)
11:22AM	FDA Issues CRL to SNY's Regulatory Filing for Multiple Sclerosis Drug (Zacks)
11:07AM	Soft Weekly Jobless Claims Data (Zacks)
10:49AM	Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying (Investopedia)
10:35AM	Xmas Eve Jobless Claims: Still Accommodating (Zacks)
09:59AM	Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise (Zacks)
09:36AM	KB Home downgraded, Costco upgraded: Wall Street's top analyst calls (The Fly)
09:36AM	KB Home downgrade, Costco upgraded: Wall Street's top analyst calls (The Fly)
09:24AM	BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax (Yahoo Finance Video)
07:59AM	This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. (Barrons.com)
07:43AM	Loading…
07:43AM	Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal (GuruFocus.com)
07:09AM	Nike, UiPath gain in premarket; Intel falls (Investing.com)
06:34AM	Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal (The Wall Street Journal)
04:27AM	Sanofi to Buy Dynavax to Boost Vaccines Business (Bloomberg)
Dec-19-25 05:40PM	Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump (Investor's Business Daily)
04:46PM	Trump reaches deal with 9 drug companies to lower prices (Yahoo Finance Video)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:09PM	More Drugmakers Reach Deals With White House to Lower Prices (The Wall Street Journal)
Dec-18-25 10:51AM	SNY's Rare Disease Drug Efdoralprin Alfa Gets EMA's Orphan Drug Tag (Zacks)
Dec-17-25 05:09PM	Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades (Insider Monkey)
Dec-16-25 01:58PM	Sanofi signs pair of billion-dollar biotech deals to bolster pipeline (Pharmaceutical Technology)
01:01PM	Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals (Pharmaceutical Technology)
10:41AM	SNY Stock Down on Double Trouble With Multiple Sclerosis Drug (Zacks)
10:30AM	FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock? (Zacks)
05:20AM	FDA proactively hands J&J a voucher; Pfizer issues 2026 forecasts (BioPharma Dive)
05:06PM	Loading…
Dec-15-25 05:06PM	Health Care Roundup: Market Talk (The Wall Street Journal)
09:34AM	Stocks to Watch Monday: iRobot, EchoStar, Juventus (The Wall Street Journal)
07:47AM	Sanofi shares fall 6% after double setback for MS drug tolebrutinib (Clinical Trials Arena)
07:41AM	iRobot's stock tumbles on bankrupcty news and other early market movers (MarketWatch)
06:04AM	Sanofi MS drug hits two setbacks (BioPharma Dive)
05:03AM	Sanofi Shares Fall After Multiple Sclerosis Drug Gets Hit by Double Setback (The Wall Street Journal)
04:43AM	Sanofi stock slumps after two setbacks on multiple-sclerosis drug (MarketWatch)
01:56AM	Sanofi Multiple Sclerosis Drug Hit by Double Setback (The Wall Street Journal)
Dec-12-25 10:30AM	Kymera's Eczema Drug Gets Fast Track Designation in the United States (Zacks)
07:25AM	Sanofi (SNY) Sees Slight Pessimism From Analysts (Insider Monkey)
06:33AM	China's NMPA approves Sanofi's rare haematologic disease treatments (Pharmaceutical Business Review)
Dec-11-25 04:28PM	Top Stock Reports for Caterpillar, Shopify & Qualcomm (Zacks)
01:42AM	Sanofis Bleeding-Disorder Treatments Get Approval in China (The Wall Street Journal)
Dec-10-25 11:28AM	JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EUR 105 (Insider Monkey)
10:33AM	Why Wall Street Analysts Are Closely Watching Sanofi (SNY) (Insider Monkey)
09:43AM	TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia (Zacks)
Dec-09-25 11:39AM	?Sanofi (SNY) Completes the Acquisition of Vicebio (Insider Monkey)
11:12AM	Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play (Zacks)
10:43AM	KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study (Zacks)
Dec-08-25 04:07PM	Kymera Rockets, Pulling Nurix Higher. Does It Have The Next Dupixent? (Investor's Business Daily)
Dec-05-25 09:57AM	Can Galafold Continue to Drive Amicus' Top Line in 2026? (Zacks)
05:42AM	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi (Zacks)
Dec-04-25 09:27AM	3 Large Drug Stocks to Watch as the Industry Shows Some Recovery (Zacks)
Dec-01-25 09:48AM	REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? (Zacks)
Nov-28-25 02:19AM	Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) (Insider Monkey)
Nov-26-25 04:11PM	Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation (Investor's Business Daily)
01:37PM	Dupixent gains chronic spontaneous urticaria indication in Europe (Pharmaceutical Technology)
09:49AM	Will Soft Gardasil Demand Continue to Dampen Merck's Top Line? (Zacks)
07:33AM	Kymera Trades Near 52-Week High: Time to Buy, Sell or Hold the Stock? (Zacks)
Nov-25-25 10:45AM	SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria (Zacks)
Nov-20-25 09:19AM	REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD (Zacks)
08:00AM	This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy. (Barrons.com)
Nov-15-25 02:15AM	How to Get Workers Back to the Office? Fresh Air, Bees, and Farmers Markets. (Barrons.com)
Nov-11-25 01:16AM	The Zacks Analyst Blog Accenture, Sanofi and Dell (Zacks)
Nov-10-25 03:25PM	Top Research Reports for Accenture, Sanofi & Dell Technologies (Zacks)
01:39PM	Why Roche Holding Stock Popped Today (Motley Fool)
Nov-08-25 02:30PM	Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60% (Investor's Business Daily)
Nov-07-25 11:27AM	Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised (Zacks)
Nov-06-25 09:01AM	Novavax beats revenue estimates, raises full-year guidance (Investing.com)
Oct-28-25 03:03PM	REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase (Zacks)
02:26PM	BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy (Zacks)
Oct-24-25 07:03PM	Analyst Report: Sanofi (Morningstar Research)
04:12PM	Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue (Investor's Business Daily)
03:02PM	Sanofi SA (SNY) Q3 2025 Earnings Call Highlights: Strong Growth Driven by DUPIXENT and New Launches (GuruFocus.com)
10:01AM	Sanofi Q3 Earnings Beat, Dupixent Drives Growth as Vaccines Decline (Zacks)
08:53AM	Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion (Investor's Business Daily)
04:45AM	Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue (The Wall Street Journal)
02:55AM	Sanofi Earnings Driven by New Medicine Sales, Dupixent Performance (The Wall Street Journal)
Oct-23-25 07:00PM	September CPI report, earnings, consumer data: What to Watch (Yahoo Finance Video)
05:39PM	Review & Preview: Inflation Data, Baby! (Barrons.com)
Oct-22-25 10:18AM	SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study (Zacks)
Oct-19-25 07:33AM	Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week (Yahoo Finance)
Oct-17-25 12:20PM	Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings? (Zacks)
Oct-16-25 06:00AM	EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi (PR Newswire)
02:54AM	REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised) (Zacks)
Oct-14-25 01:33PM	Top Novavax Shareholder Demands Companys Sale (Barrons.com)
Oct-13-25 10:15AM	TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder (Zacks)
10:02AM	REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Zacks)
Oct-10-25 04:12PM	Top Research Reports for Walmart, Sony & Citigroup (Zacks)
Oct-09-25 04:03PM	Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out (Investor's Business Daily)
11:55AM	RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes (Zacks)
09:15AM	Regeneron Gets FDA Nod for Label Expansion of Oncology Drug Libtayo (Zacks)
Oct-05-25 02:42AM	Sanofi (SNY) Invests $625 Million in Sanofi Ventures (Insider Monkey)
Oct-02-25 09:40AM	Can Galafold Drive Amicus' Growth Through the Rest of 2025? (Zacks)
08:00AM	Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes (Business Wire)
Oct-01-25 08:15PM	Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating (Insider Monkey) +5.42%
09:38AM	Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline (Zacks)
Sep-30-25 01:06PM	Pfizers Trump Deal Eases Drug Pricing, Tariff Pressure. Drug Stocks Are Up. (Barrons.com)
11:26AM	Pfizer, Other Drug Stocks Jump on Reports of Trump Pricing Plan (Barrons.com)
Sep-29-25 04:25PM	GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley (Investor's Business Daily)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNY

Sanofi ADR

Upgrade your FINVIZ experience